CD4 and neoplasm: CD4+ and CD8+ tumor infiltrating lymphocytes (TILs) have been well documented in gliomas as a predictor of post-treatment patient outcomes and high percentages of CD4+ and CD8+ TILs have been correlated with the presence of PsP [18].